TAM
CORT icon

Tyers Asset Management’s Corcept Therapeutics CORT Stock Holding History

Tyers Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,244
Closed -$148K – 1003
2019
Q2 		$148K Buy
13,244
+858
+7% +$9.56K 0.01% 785
2019
Q1 		$145K Hold
12,386
– – 0.01% 781
2018
Q4 		$166K Buy
12,386
+990
+9% +$13.1K 0.01% 714
2018
Q3 		$160K Buy
11,396
+3,124
+38% +$43.7K 0.01% 797
2018
Q2 		$130K Hold
8,272
– – ﹤0.01% 796
2018
Q1 		$136K Buy
+8,272
New +$153K ﹤0.01% 786

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tyers Asset Management's CORT Position: Q3 2019 in Review

Tyers Asset Management sold out of Corcept Therapeutics (CORT) in Q3 2019, closing a stake of 13,244 shares — an estimated $148K sold.

Tyers Asset Management first reported a position in CORT in Q1 2018 and held it in 6 quarters. The position peaked at $166K in Q4 2018. 193 funds tracked by Wall St. Rank hold CORT as of Q3 2019.

  • Tyers Asset Management reported no remaining Corcept Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Tyers Asset Management sold 13,244 Corcept Therapeutics shares in Q3 2019, an estimated $148K.
  • Tyers Asset Management first reported a position in Corcept Therapeutics in Q1 2018 and held it in 6 quarters.
  • Tyers Asset Management's Corcept Therapeutics position peaked at $166K in Q4 2018.
  • 193 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.